A Trial In Patients With Advanced Cancer And Leukemia
NCT00878189
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms by Histologic Type
Interventions
DRUG:
PF-03084014
Sponsor
Pfizer